Galapagos NV
GLPG
#4563
Rank
S$2.73 B
Marketcap
S$40.94
Share price
-0.57%
Change (1 day)
13.48%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): S-$0.42

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is S-$0.44. In 2024 the company made an earnings per share (EPS) of S$1.51 a decrease over its 2023 EPS that were of S$4.60.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.42-128.09%
2024S$1.51-67.16%
2023S$4.60-199.64%
2022S-$4.6299.03%
2021S-$2.32-68.98%
2020S-$7.48-298.06%
2019S$3.77-554.64%
2018S-$0.83-77.18%
2017S-$3.64-326.21%
2016S$1.61-134.19%
2015S-$4.70-371.34%
2014S$1.73-445.98%
2013S-$0.5032.88%
2012S-$0.38-82.07%
2011S-$2.10-817.9%
2010S$0.2912.73%
2009S$0.26-120.79%
2008S-$1.25-37.67%
2007S-$2.0139.64%
2006S-$1.4428.17%
2005S-$1.126.25%
2004S-$1.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
S$3.93-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$13.53-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.80-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$1.75-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S-$1.90 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.44-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.82-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$4.66-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$9.84-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA